Michael Miller, MD

Michael Miller, MD

Cardiology Baltimore, MD

Professor, Medicine, University of Maryland School of Medicine

Office Address

    Baltimore, MD 21201
    Phone: (410) 328-6299

Michael Miller, MD

Cardiology Baltimore, MD

Professor, Medicine, University of Maryland School of Medicine


  • Dr. Miller is a cardiologist and authority in heart disease prevention. He is past president of the American Society of Preventive Cardiology, chaired the American Heart Association's national statement on triglycerides and heart disease and is a Council Member of the AHA Nutrition and Lifestyle Committee.

    Dr. Miller's new book, "Heal Your Heart: The Positive Emotions Prescription to Prevent and Reverse Heart Disease" draws upon 30-years of patient care and scientific research experience. See www.healyourheartbook.com
    or http://www.amazon.com/Heal-Your-Heart-Michael-Miller-ebook/dp/B00PG992UY

Clinical Specialties & Interests

  • Cardiology: General Cardiology, Interventional
  • Clinical Interests: Coronary Disease; Lipid Metabolism; Vascular Endothelium; Risk Factors; Positive Emotions

Education & Training

  • Johns Hopkins UniversityJohns Hopkins University
  • Johns Hopkins UniversityJohns Hopkins University
  • University Hospital - University of Cincinnati College of MedicineUniversity Hospital - University of Cincinnati College of Medicine
  • Rutgers Robert Wood Johnson Medical SchoolRutgers Robert Wood Johnson Medical School
  • Rutgers College

Certifications & Licensure

  • CA State Medical LicenseCA State Medical LicenseActive through 2015
  • MD State Medical LicenseMD State Medical LicenseActive through 2016
  • American Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineCardiovascular Disease

    Awards, Honors, & Recognition

    • Most Influential Doctors (Cholesterol)USA TODAY
    • America's Top DoctorsCastle Connelly
    • Cholesterol AdvisorNational Library of Medicine, 2013

    Clinical Trials

    Publications & Presentations


    Journal Articles

    • High-Density Lipoproteins: A Consensus Statement from the National Lipid Association  Toth PP, Barter PJ, Rosenson RS, Boden WE, Chapman J, Cuchel M, D’Agostino RB, Davidson MH, Davidson S, Heinecke JW, Karas RH, Kontush A, Krauss RM, Miller M, Rader DJ, J Clin Lipidol, 1/1/2013
    • LDL Cholesterol: The Lower the Better  Martin SS, Blumenthal RS, Miller M, Med Clin North Am., 1/1/2012
    • Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and HDL composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study  Ballantyne CM, Miller M, Kallend D, Niesor E, Am Heart J, 1/1/2012

    Books/Book Chapters

    • Essential Cardiology: Principles and Practice Chapter: Preventive Cardiology. Page 767 - 780
      Aja TA, Miller M
      Editors: Clive Rosendorff.W.B. Saunders, Philadelphia
      Edition 3rd,2013
    • Preventive Cardiology: A Companion to Braunwald's Heart Disease Chapter: The role of high-density lipoprotein cholesterol in the development of atherosclerotic cardiovascular disease. Page 204 - 215
      Gandotra P, Miller M
      Editors: Blumenthal RS, Foody JM, Wong ND.
    • The Johns Hopkins Textbook of Dyslipidemia Chapter: Disorders of Hypertriglyceridemia. Page 74 - 88
      Miller M
      Editors: Kwiterovich PO.Lippincott, Williams & Wilkins, Baltimore, MD


    • Remnant cholesterol predicts short and long-term recurrent ischemic events after acute coronary syndrome. Schwartz GG, Abt M, Bao W, DeMicco D, Miller M, Mundl H, Olsson AG, 64th Annual Scientific Sessions of the American College of Cardiology, Washington, DC, 3/31/2014
    • Low HDL-C and Prediction of CHD Risk in Subjects with Normal TG and LDL-C Levels. The Framingham Offspring Study. Miller M, Kim Y, Havas S, Kwiterovich PO, Fazio S, 64th Annual Scientific Sessions of the American College of Cardiology, Washington, DC, 3/31/2014
    • Does the Metabolic Syndrome Cluster Provide Incremental Prognostic Information Over the Individual Components? Post Hoc Analysis of the AIM-HIGH Trial. Boden WE, Robinson JG, Miller M, Simmons D, Xu S, Abramson B, Elam MB, Nash SD, Brown TM, McBride, Fleg JL, Desvigne-Nickens P, Probstfield JL, 75th Annual Scientific Sessions of the AHA, Dallas, TX, 11/1/2013


    • “Medications should routinely be used to treat triglycerides between 200-500 mg/dL." Protagonist; (Sanjay Kaul, Antagonist). 3/30/2014
    • PriMed Update: Managing the patient with high triglycerides; Assessment and Treatment Strategies. Ft. Lauderdale, FL - 2/6/2014
    • Cardiovascular Disease Arena-Focus on Glycemic Control Dallas, TX - 11/18/2013



    • AHA Nutrition and Lifestyle Committee Council Member 2014 - Present
    • Governor's Council Heart Disease and Stroke Prevention Member 2013 - Present
    • Journal of the American College of Cardiology Section Editor-Clinical Trials and Registries 2014 - Present

    Other Languages

    • Italian

    Insurance Accepted

    • Aetna Choice POS II
    • Aetna HMO
    • BCBS Blue Card PPO
    • CareFirst BlueChoice Advantage
    • CareFirst BlueChoice Network POS
    • CareFirst BluePreferred PPO
    • CIGNA Open Access
    • First Health PPO
    • Humana ChoiceCare Network PPO
    • Multiplan PHCS PPO
    • Multiplan PPO
    • United Healthcare - Direct Choice Plus POS
    • United Healthcare - Direct Options PPO


    • The full profile is locked and available to verified physicians only.
      Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Miller's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV